Real-time enrollment status for this lymphoma receiving car-t therapy clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 11:18 PM UTC
| NCT Number | NCT04107285 |
| Recruiting Status | Recruiting |
| Condition | Lymphoma Receiving CAR-T Therapy |
| Phase | Clinical Trial |
| Target Enrollment | 120 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Updated on CT.gov | October 24, 2025 (Oct 24, 2025) |
As of July 17, 2026: Clinical trial NCT04107285 is currently recruiting participants. This clinical trial study for lymphoma receiving car-t therapy is actively seeking new participants at 1 location across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04107285 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04107285 was last updated Oct 24, 2025 (October 24, 2025). HelloStudys verifies this status automatically.